# Abpro Holdings Inc (ABP)

Source: https://www.quantisnow.com/company/ABP
Generated: 2026-11-10T18:51:15.329Z

- Ticker: ABP
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2022

## Latest ABP news and filings

- 2026-02-20 21:15 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-notice-of-delisting-6404835)
- 2026-02-11 21:15 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-notice-of-delisting-6386736)
- 2026-02-09 21:07 UTC [SEC Form SCHEDULE 13G filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-abpro-holdings-inc-6381723)
- 2026-02-03 21:15 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-leadership-update-6372459)
- 2026-01-23 21:16 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-entry-into-a-6359247)
- 2026-01-06 12:06 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6337153)
- 2026-01-06 12:00 UTC [Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72](https://www.quantisnow.com/insight/abpro-and-celltrion-inc-announce-us-fda-ind-clearance-for-6337092)
- 2025-12-15 12:16 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6315241)
- 2025-12-15 12:00 UTC [Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers](https://www.quantisnow.com/insight/abpro-holdings-announces-submission-of-an-ind-application-to-initiate-6315203)
- 2025-12-09 12:08 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6307941)
- 2025-12-09 12:00 UTC [Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives](https://www.quantisnow.com/insight/abpro-granted-nasdaq-listing-extension-to-pursue-compliance-and-strategic-6307888)
- 2025-12-03 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-effect-filed-by-abpro-holdings-inc-6300541)
- 2025-11-28 19:15 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-abpro-holdings-inc-6296281)
- 2025-11-17 21:16 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-abpro-holdings-inc-6282992)
- 2025-11-14 21:47 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-abpro-holdings-inc-6281188)
- 2025-11-07 12:41 UTC [SEC Form S-1] [SEC Form S-1 filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-abpro-holdings-inc-6267251)
- 2025-11-04 15:45 UTC [SEC Form 8-K] [Amendment: Abpro Holdings Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-abpro-holdings-inc-filed-sec-form-8-k-regulation-fd-6258560)
- 2025-11-04 14:15 UTC [Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager](https://www.quantisnow.com/insight/abpro-and-celltrion-to-present-preclinical-data-for-ct-p72abp-102-at-6258460)
- 2025-11-04 12:00 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6257882)
- 2025-11-03 12:00 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6255375)
- 2025-11-03 12:00 UTC [Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025](https://www.quantisnow.com/insight/abpro-announces-1-for-30-reverse-stock-split-effective-november-3-2025-6255344)
- 2025-10-22 21:00 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-amendments-to-articles-6242034)
- 2025-10-17 20:15 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-notice-of-delisting-6237061)
- 2025-10-14 11:03 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-submission-of-matters-6231313)
- 2025-10-06 20:15 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-abpro-holdings-inc-6224680)
- 2025-10-03 20:15 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-notice-of-delisting-6222614)
- 2025-10-02 20:15 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-leadership-update-6220166)
- 2025-09-18 20:15 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-abpro-holdings-inc-6205650)
- 2025-09-16 20:18 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-abpro-holdings-inc-6202560)
- 2025-09-08 20:18 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-abpro-holdings-inc-6193369)
- 2025-09-08 11:00 UTC [Leadership Update] [Sitryx appoints Adam Mostafa as Chief Financial Officer](https://www.quantisnow.com/insight/sitryx-appoints-adam-mostafa-as-chief-financial-officer-6192431)
- 2025-08-29 20:21 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-abpro-holdings-inc-6183853)
- 2025-08-13 20:56 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-abpro-holdings-inc-6163599)
- 2025-08-13 20:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-abpro-holdings-inc-6163260)
- 2025-08-07 13:08 UTC [SEC Form 4] [SEC Form 4 filed by Director Lee Soo Young](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-lee-soo-young-6152796)
- 2025-08-04 21:22 UTC [Insider Buy] [CEO and Chairman Suk Jin Wook (Miles) bought $20,170 worth of shares (72,035 units at $0.28), increasing direct ownership by 11% to 718,512 units (SEC Form 4)](https://www.quantisnow.com/insight/ceo-and-chairman-suk-jin-wook-miles-bought-20170-worth-6145488)
- 2025-07-30 01:23 UTC [SEC Form 4] [SEC Form 4 filed by Director Eisenberg Anthony D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-eisenberg-anthony-d-6137285)
- 2025-07-29 12:42 UTC [SEC Form 4] [CEO and Chairman Suk Jin Wook (Miles) was granted 500,000 shares, increasing direct ownership by 341% to 646,477 units (SEC Form 4)](https://www.quantisnow.com/insight/ceo-and-chairman-suk-jin-wook-miles-was-granted-500000-6135624)
- 2025-07-24 20:15 UTC [SEC Form 8-K] [Abpro Holdings Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abpro-holdings-inc-filed-sec-form-8-k-leadership-update-financial-6131725)
- 2025-06-18 20:37 UTC [SEC Form S-8] [SEC Form S-8 filed by Abpro Holdings Inc](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-abpro-holdings-inc-6092093)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ABP
- Earnings history: https://www.quantisnow.com/earnings/ABP
- Dividend history: https://www.quantisnow.com/dividends/ABP
- Insider transactions: https://www.quantisnow.com/insiders/ABP
- Options chain: https://www.quantisnow.com/options/ABP
- SEC 8-K filings only: https://www.quantisnow.com/company/ABP/8-k
- RSS and alerts for ABP: https://www.quantisnow.com/docs/rss-feeds.md